My menopause patch disappeared, and I started asking bigger questions For weeks, my hormone replacement therapy (HRT) patch had been a consistent part of my daily routine, helping me navigate the challenges of menopause with improved sleep, mental clarity, and emotional stability. But one day, it was gone, no longer available at local pharmacies. The patch, which had been a lifeline, was simply unavailable. As someone trained in medicine, I understood that drug shortages could stem from a variety of factors, including production delays, supply chain breakdowns, or regulatory changes. Yet, despite these explanations, the reality remained unchanged: the medicine was still inaccessible. I began reaching out to different pharmacies, eventually securing a higher-dose alternative. However, this new patch triggered severe headaches, forcing me to reconsider my options. In a moment of desperation, I even thought about cutting the patch in half, an instinctive response to a crisis. This experience underscored how quickly a well-planned treatment can unravel when faced with unexpected obstacles. I reached out to pharmacists at two major pharmacy chains in South Africa, seeking insight into the broader implications of medication unavailability. When I asked what happened when erectile dysfunction drugs were out of stock, one pharmacist responded with a dry chuckle: “Men complain loudly; they fight. We make sure we have stock.” While this anecdote may not represent a universal truth, it raises uncomfortable questions about the priorities within the healthcare system. Why do some conditions receive greater attention than others? What does it mean when certain medications are consistently available while others are not? Menopause, a condition affecting nearly half the global population, is often dismissed as a natural consequence of aging rather than a medical concern requiring intervention. This perception contributes to the underestimation of its impact, both physically and emotionally. Women experiencing menopause symptoms may find themselves navigating a complex landscape of stigma, misunderstanding, and limited support. Unlike other health conditions, menopause is rarely framed as an urgent issue demanding immediate action. The consequences of inadequate access to HRT extend beyond individual suffering. A teacher struggling with irritability, a nurse losing focus during critical moments, or an executive failing to perform effectively in meetings, all these scenarios reflect the ripple effect of untreated menopausal symptoms. These effects are not confined to the individual; they influence family dynamics, workplace productivity, and community well-being. Women who lack proper treatment may internalize their symptoms, leading to diminished self-esteem and a sense of helplessness. Access to HRT is not solely dependent on having a prescription. It requires a functioning healthcare infrastructure capable of delivering consistent, reliable care. Many women find themselves in a cycle of frustration, bouncing between pharmacies, relying on online resources, or even resorting to informal networks like WhatsApp groups to locate supplies. Some may choose to ration their medication, further compounding the problem. When I finally retrieved my patch, I discovered that a single pharmacy had only three boxes in stock. I took all three, driven by a deep-seated fear of disruption. To me, this wasn’t mere hoarding, it was a survival strategy born from uncertainty. My trust in the supply chain has been irreparably shaken. This situation highlights a systemic failure, not just in pharmaceutical distribution, but in the broader approach to women's health. Awareness of menopause is growing, but so too is the recognition that access to effective treatment remains a persistent challenge. This Women’s Month, the conversation must shift from awareness to tangible action. Is HRT truly viewed as an essential medicine in both public and private healthcare systems? Until then, women will continue to bear the burden of unmet needs, forced to navigate a system that often overlooks their voices.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter